84 related articles for article (PubMed ID: 21918876)
21. Conformational studies of mono- and bicyclic parathyroid hormone-related protein-derived agonists.
Mierke DF; Maretto S; Schievano E; DeLuca D; Bisello A; Mammi S; Rosenblatt M; Peggion E; Chorev M
Biochemistry; 1997 Aug; 36(34):10372-83. PubMed ID: 9265617
[TBL] [Abstract][Full Text] [Related]
22. Mono- and bicyclic analogs of parathyroid hormone-related protein. 2. Conformational analysis of antagonists by CD, NMR, and distance geometry calculations.
Maretto S; Mammi S; Bissacco E; Peggion E; Bisello A; Rosenblatt M; Chorev M; Mierke DF
Biochemistry; 1997 Mar; 36(11):3300-7. PubMed ID: 9116008
[TBL] [Abstract][Full Text] [Related]
23. The 10th and 11th residues of short length N-terminal PTH(1-12) analogue are important for its optimum potency.
Lim SK; Lee EJ; Kim HY; Lee W
J Pept Res; 2004 Jul; 64(1):25-32. PubMed ID: 15200475
[TBL] [Abstract][Full Text] [Related]
24. Human growth hormone-releasing hormone hGHRH(1-29)-NH2: systematic structure-activity relationship studies.
Cervini LA; Donaldson CJ; Koerber SC; Vale WW; Rivier JE
J Med Chem; 1998 Feb; 41(5):717-27. PubMed ID: 9513600
[TBL] [Abstract][Full Text] [Related]
25. Solution structure of the osteogenic 1-31 fragment of the human parathyroid hormone.
Chen Z; Xu P; Barbier JR; Willick G; Ni F
Biochemistry; 2000 Oct; 39(42):12766-77. PubMed ID: 11041841
[TBL] [Abstract][Full Text] [Related]
26. Mono- and bicyclic analogs of parathyroid hormone-related protein. 1. Synthesis and biological studies.
Bisello A; Nakamoto C; Rosenblatt M; Chorev M
Biochemistry; 1997 Mar; 36(11):3293-9. PubMed ID: 9116007
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.
Lung FD; Collins N; Stropova D; Davis P; Yamamura HI; Porreca F; Hruby VJ
J Med Chem; 1996 Mar; 39(5):1136-41. PubMed ID: 8676350
[TBL] [Abstract][Full Text] [Related]
28. Conformation and interactions of bombolitin I analogues with SDS micelles and phospholipid vesicles: CD, fluorescence, two-dimensional NMR and computer simulations.
Chorev M; Gurrath M; Behar V; Mammi S; Tonello A; Peggion E
Biopolymers; 1995 Oct; 36(4):473-84. PubMed ID: 7578942
[TBL] [Abstract][Full Text] [Related]
29. Effects of side-chain characteristics on stability and oligomerization state of a de novo-designed model coiled-coil: 20 amino acid substitutions in position "d".
Tripet B; Wagschal K; Lavigne P; Mant CT; Hodges RS
J Mol Biol; 2000 Jul; 300(2):377-402. PubMed ID: 10873472
[TBL] [Abstract][Full Text] [Related]
30. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
[TBL] [Abstract][Full Text] [Related]
31. Structural requirements for conserved arginine of parathyroid hormone.
Barbier JR; MacLean S; Whitfield JF; Morley P; Willick GE
Biochemistry; 2001 Jul; 40(30):8955-61. PubMed ID: 11467957
[TBL] [Abstract][Full Text] [Related]
32. Ligand-receptor interactions at the parathyroid hormone receptors: subtype binding selectivity is mediated via an interaction between residue 23 on the ligand and residue 41 on the receptor.
Mann R; Wigglesworth MJ; Donnelly D
Mol Pharmacol; 2008 Sep; 74(3):605-13. PubMed ID: 18539702
[TBL] [Abstract][Full Text] [Related]
33. Folding of peptides characterized by c3Val, a highly constrained analogue of valine.
Peggion C; Formaggio F; Crisma M; Toniolo C; Jiménez AI; Cativiela C; Kaptein B; Broxterman QB; Saviano M; Benedetti E
Biopolymers; 2003 Feb; 68(2):178-91. PubMed ID: 12548622
[TBL] [Abstract][Full Text] [Related]
34. Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges.
Koerber SC; Gulyas J; Lahrichi SL; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
J Med Chem; 1998 Dec; 41(25):5002-11. PubMed ID: 9836618
[TBL] [Abstract][Full Text] [Related]
35. Controlling the helical screw sense of peptides with C-terminal L-valine.
Demizu Y; Yamagata N; Sato Y; Doi M; Tanaka M; Okuda H; Kurihara M
J Pept Sci; 2010 Mar; 16(3):153-8. PubMed ID: 20127855
[TBL] [Abstract][Full Text] [Related]
36. How insulin binds: the B-chain alpha-helix contacts the L1 beta-helix of the insulin receptor.
Huang K; Xu B; Hu SQ; Chu YC; Hua QX; Qu Y; Li B; Wang S; Wang RY; Nakagawa SH; Theede AM; Whittaker J; De Meyts P; Katsoyannis PG; Weiss MA
J Mol Biol; 2004 Aug; 341(2):529-50. PubMed ID: 15276842
[TBL] [Abstract][Full Text] [Related]
37. Bioactivities and secondary structures of constrained analogues of human parathyroid hormone: cyclic lactams of the receptor binding region.
Barbier JR; Neugebauer W; Morley P; Ross V; Soska M; Whitfield JF; Willick G
J Med Chem; 1997 Apr; 40(9):1373-80. PubMed ID: 9135034
[TBL] [Abstract][Full Text] [Related]
38. N-terminal phosphorylation of parathyroid hormone (PTH) abolishes its receptor activity.
Kumar A; Gopalswamy M; Wishart C; Henze M; Eschen-Lippold L; Donnelly D; Balbach J
ACS Chem Biol; 2014 Nov; 9(11):2465-70. PubMed ID: 25158085
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterization of the receptor-ligand complex for parathyroid hormone.
Rölz C; Pellegrini M; Mierke DF
Biochemistry; 1999 May; 38(20):6397-405. PubMed ID: 10350457
[TBL] [Abstract][Full Text] [Related]
40. C-terminal analogues of parathyroid hormone: effect of C-terminus function on helical structure, stability, and bioactivity.
Potetinova Z; Barbier JR; Suen T; Dean T; Gardella TJ; Willick GE
Biochemistry; 2006 Sep; 45(37):11113-21. PubMed ID: 16964972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
